GPRC5A and permanent neonatal diabetes mellitus-pancreatic and cerebellar agenesis syndrome: Mechanistically, GPRC5A may act as an oncogene in the progression of PaCa mainly via regulating epithelial-mesenchymal transition (EMT) and neuroactive ligand-receptor interaction.